Medications developed to control blood sugar are now at the center of a very different scientific story: how they might raise ...

Researchers caution that while the findings are promising, the observational study does not prove that GLP-1 drugs prevent ...

Meet Athul, a sixth grader from Kerala who bravely manages Type 1 diabetes daily, carrying insulin and a glucometer to school ...

Global pharma giants Eli Lilly and Novo Nordisk are scrambling to cement their lead in India's booming obesity drug market ...

GLP-1 medications like semaglutide in Ozempic and Wegovy help people lose weight. But they need to be taken for years, ...

The US Food and Drug Administration on Monday approved a daily pill version of Novo Nordisk's weight-loss drug Wegovy, ...

Immutep ( ($IMMP) ) has issued an announcement. On 22 December 2025, Immutep reported positive initial results from a placebo-controlled, ...

The Food and Drug Administration on Monday approved a pill version of the weight-loss injectable drug Wegovy, offering ...

Trial to assess cadisegliatin as potential adjunctive therapy to insulin in patients with T2DHIGH POINT, N.C., Dec. 18, 2025 ...

Single-ascending dose portion of study has successfully completed 2.5 and 7 mg / kg levelsDose dependent immunosuppressive ...

M42 is committed to the sustainable future of global health – from Abu Dhabi to the world. The company’s strategy involves leveraging technology not as a mere tool but as a transformative force in ...

Health-related social needs in HF, removing age from frailty scores, CIED concerns about smartwatches, and more.